Muscarinic receptor subtypes in hippocampus in Alzheimer's disease and mixed dementia type.
Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
[A case report of mixed type dementia combining Binswanger's disease with senile dementia of Alzheimer's type].
Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.
Hartley SL, Fleming V, Schworer EK, Peven J, Handen BL, Krinsky-McHale S, Hom C, Lee L, Tudorascu DL, Laymon C, Minhas D, Luo W, Cohen A, Zaman S, Ances BM, Mapstone M, Head E, Lai F, Rosas HD, Klunk W, Christian B; Alzheimer Biomarker Consortium-Down Syndrome.
J Alzheimers Dis. 2023;95(1):213-225. doi: 10.3233/JAD-230200.
Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.
Hierro-Bujalance C, Infante-Garcia C, Del Marco A, Herrera M, Carranza-Naval MJ, Suarez J, Alves-Martinez P, Lubian-Lopez S, Garcia-Alloza M.
Alzheimers Res Ther. 2020 Apr 7;12(1):40. doi: 10.1186/s13195-020-00607-4.
Cardiovascular risk factors of Alzheimer's disease and other neurocognitive disorders in Malaysia.
Ibrahim B, Suppiah S, Piersson AD, Razali RM, Mohamad M, Abu Hassan H, Ibrahim N.
Med J Malaysia. 2021 May;76(3):291-297.
Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer's disease-associated genetic variants.
He L, Loika Y, Kulminski AM.
Transl Psychiatry. 2022 Apr 18;12(1):163. doi: 10.1038/s41398-022-01913-1.
Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, beta-secretase, and amyloid beta aggregation as potential treatment of Alzheimer's disease.
Zaręba P, Łątka K, Mazur G, Gryzło B, Pasieka A, Godyń J, Panek D, Skrzypczak-Wiercioch A, Höfner GC, Latacz G, Maj M, Espargaró A, Sabaté R, Jóźwiak K, Wanner KT, Sałat K, Malawska B, Kulig K, Bajda M.
Eur J Med Chem. 2023 Dec 5;261:115832. doi: 10.1016/j.ejmech.2023.115832. Epub 2023 Oct 7.
Cofilin promotes tau pathology in Alzheimer's disease.
Yan M, Tang L, Dai L, Lei C, Xiong M, Zhang X, He M, Tian Y, Xiong J, Ke W, Zhang Z, Zhang C, Deng X, Zhang Z.
Cell Rep. 2023 Feb 28;42(2):112138. doi: 10.1016/j.celrep.2023.112138. Epub 2023 Feb 17.
Evaluating the Role of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease.
Osmanovic-Barilar J, Salkovic-Petrisi M.
Drugs Aging. 2016 Nov;33(11):787-808. doi: 10.1007/s40266-016-0407-9.
Longitudinal head-to-head comparison of (11)C-PiB and (18)F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-beta monoclonal antibodies in dominantly inherited Alzheimer's disease.
Chen CD, McCullough A, Gordon B, Joseph-Mathurin N, Flores S, McKay NS, Hobbs DA, Hornbeck R, Fagan AM, Cruchaga C, Goate AM, Perrin RJ, Wang G, Li Y, Shi X, Xiong C, Pontecorvo MJ, Klein G, Su Y, Klunk WE, Jack C, Koeppe R, Snider BJ, Berman SB, Roberson ED, Brosch J, Surti G, Jiménez-Velázquez IZ, Galasko D, Honig LS, Brooks WS, Clarnette R, Wallon D, Dubois B, Pariente J, Pasquier F, Sanchez-Valle R, Shcherbinin S, Higgins I, Tunali I, Masters CL, van Dyck CH, Masellis M, Hsiung R, Gauthier S, Salloway S, Clifford DB, Mills S, Supnet-Bell C, McDade E, Bateman RJ, Benzinger TLS; DIAN-TU Study Team.
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5.
Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK, Kaul CL, Ramarao P.
Pharmacol Res. 2005 Jan;51(1):1-17. doi: 10.1016/j.phrs.2004.05.005.
Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia.
Jellinger KA.
Neurodegener Dis. 2008;5(3-4):118-21. doi: 10.1159/000113679. Epub 2008 Mar 6.
